Induction of IL-2 receptor expression in vivo: response to concanavalin A.
The requirements for the induction of IL-2 receptor expression following lymphocyte stimulation in vitro are well understood but little is known about the role of IL-2 and the IL-2 receptor in lymphocyte activation in vivo. Following the subcutaneous injection of concanavalin A, cells from popliteal and lumbar lymph nodes draining the footpad became enlarged and expressed the IL-2 receptor. At the peak of the response, 9-15 hr after injection, more than 70% of all cells were IL-2 receptor positive; the majority were T cells of both Lyt-2+ and L3T4+ subsets. IL-2 receptor expression was closely associated with both spontaneous and IL-2-driven proliferation. Analysis of the biodistribution of 125I-labeled concanavalin A revealed that much of the injectate remains in the footpad injection site but the mitogen also accumulates in the draining lymph nodes and eventually in the major organs. This model of lymphocyte activation was used to demonstrate that in vivo cyclosporin A inhibits both IL-2 receptor expression and the induction of spontaneous proliferation.
D000818:Animals; D000943:Antigens, Differentiation / Q000032:analysis; D003208:Concanavalin A / Q000494:pharmacology*; D003524:Cyclosporins / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000502:physiology*; D008198:Lymph Nodes / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D011971:Receptors, Immunologic / Q000502:physiology*; D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin / Q000502:physiology; D013997:Time Factors
D000943:Antigens, Differentiation; D003524:Cyclosporins; D007376:Interleukin-2; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin; D003208:Concanavalin A